2008 Summer Meeting
How to Better Detect and Prevent Adverse Events and Medication Errors in Your ICU
Track: Quality Standards
Program Code:118-L05
Date: 10 June 2008
Time: Tuesday, June 10, 2008
Location:603 - Level 6MEETING PLANNING ASSOCIATE:
| Dr. Erstad obtained his B.S. degree in pharmacy from South Dakota State University and then worked as a staff pharmacist for approximately 8 years in community hospital practice. He subsequently received his Doctor of Pharmacy degree from the University of Arizona and performed a residency at the university medical center in Tucson. Dr. Erstad has graduated from the Arizona Clinical Research Training Program, which was funded by an NIH K30 Clinical Research Curriculum Award. His research interests pertain to critical care medicine with an emphasis on blood product derivatives, infectious diseases, patient safety and related outcomes’ research- he is a Center Investigator- Center for Health Outcomes and Pharmacoeconomics Research, University of Arizona. Dr. Erstad is currently a Professor in the Department of Pharmacy Practice & Science at the University of Arizona College of Pharmacy. His clinical responsibilities are performed at University Medical Center. He has authored more than 100 peer-reviewed articles and book chapters. Dr. Erstad has received recognition as a Fellow by the following organizations: American College of Critical Care Medicine, American Society of Health-System Pharmacists, and the American College of Clinical Pharmacy (ACCP). He has received the ACCP Clinical Practice Award and the ACCP Education Award. |
MODERATOR:
| Dr. Erstad obtained his B.S. degree in pharmacy from South Dakota State University and then worked as a staff pharmacist for approximately 8 years in community hospital practice. He subsequently received his Doctor of Pharmacy degree from the University of Arizona and performed a residency at the university medical center in Tucson. Dr. Erstad has graduated from the Arizona Clinical Research Training Program, which was funded by an NIH K30 Clinical Research Curriculum Award. His research interests pertain to critical care medicine with an emphasis on blood product derivatives, infectious diseases, patient safety and related outcomes’ research- he is a Center Investigator- Center for Health Outcomes and Pharmacoeconomics Research, University of Arizona. Dr. Erstad is currently a Professor in the Department of Pharmacy Practice & Science at the University of Arizona College of Pharmacy. His clinical responsibilities are performed at University Medical Center. He has authored more than 100 peer-reviewed articles and book chapters. Dr. Erstad has received recognition as a Fellow by the following organizations: American College of Critical Care Medicine, American Society of Health-System Pharmacists, and the American College of Clinical Pharmacy (ACCP). He has received the ACCP Clinical Practice Award and the ACCP Education Award. |
PRESENTER(S):
| Dr. Erstad obtained his B.S. degree in pharmacy from South Dakota State University and then worked as a staff pharmacist for approximately 8 years in community hospital practice. He subsequently received his Doctor of Pharmacy degree from the University of Arizona and performed a residency at the university medical center in Tucson. Dr. Erstad has graduated from the Arizona Clinical Research Training Program, which was funded by an NIH K30 Clinical Research Curriculum Award. His research interests pertain to critical care medicine with an emphasis on blood product derivatives, infectious diseases, patient safety and related outcomes’ research- he is a Center Investigator- Center for Health Outcomes and Pharmacoeconomics Research, University of Arizona. Dr. Erstad is currently a Professor in the Department of Pharmacy Practice & Science at the University of Arizona College of Pharmacy. His clinical responsibilities are performed at University Medical Center. He has authored more than 100 peer-reviewed articles and book chapters. Dr. Erstad has received recognition as a Fellow by the following organizations: American College of Critical Care Medicine, American Society of Health-System Pharmacists, and the American College of Clinical Pharmacy (ACCP). He has received the ACCP Clinical Practice Award and the ACCP Education Award. |
Dr. Brian Kopp, PharmD, BCPS, Clinical Pharmacist, University Medical Center
| Brian Kopp graduated with his doctorate in pharmacy from the University of Arizona College of Pharmacy. He completed pharmacy practice and critical care residencies at University Medical Center in Tucson, Arizona. Dr. Kopp currently serves as a Clinical Pharmacist on the Surgery/Trauma ICU at University Medical Center and is a preceptor for the accredited general and specialized residency (critical care/nutrition) programs. In addition, he serves as Clinical Assistant Professor at the University of Arizona College of Pharmacy. Dr. Kopp’s research interests concern patient safety issues and documentation of the benefits of pharmacists in the intensive care unit setting. Dr. Kopp is a Board Certified Pharmacotherapy Specialist (BCPS). |
Description:
The majority of studies that have investigated ADEs and medication errors in patients in the ICU involve chart reviews and voluntary incident reporting techniques. Direct observation is another method that has been used to detect ADEs and medication errors in hospitalized patients. However, until recently, there were no investigations that used a continuous observation approach to look at the overall medication-use process that leads to medication errors and preventable ADEs in the ICU setting. This session was planned in cooperation with the ASHP Quality Improvement Initiative.
Learning Objectives:
- List two limitations of traditional approaches to detecting adverse drug events and medication errors in the ICU setting.
- Compare the advantages and disadvantages of chart review and incident reporting techniques for detecting adverse drug events and medication errors compared to a direct observation approach.
- Discuss options for decreasing adverse drug events and medication errors based on their stage of occurrence.
